COLUMBIA, Md., Sept. 15 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that it will be participating in two upcoming investor conferences. On Monday, September 21, 2009 at 12:30 p.m. EDT, Peter Buzy, Chief Financial Officer, will be presenting at the UBS Global Life Sciences Conference in New York, NY. The conference is being held September 21-23, 2009 at the Grand Hyatt hotel.
On Wednesday, September 23, 2009 at 8:30 a.m. EDT, Steve Dubin, Chief Executive Officer, and Peter Buzy, Chief Financial Officer, will be presenting at the Canaccord Adams Healthy Living Conference in Boston, MA.
Live audio webcasts of both of Martek's presentations can be accessed at: http://investors.martek.com.
Martek Biosciences Corporation is a leader in the innovation and development of omega-3 DHA products that promote health and wellness through every stage of life. The Company produces life'sDHA(TM), a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, infant formula and supplements, and life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com.
Contact: Kyle Stults Investor Relations (410) 740-0081
|SOURCE Martek Biosciences Corporation|
Copyright©2009 PR Newswire.
All rights reserved